Form 8-K - Current report:
SEC Accession No. 0001193125-12-257348
Filing Date
2012-06-01
Accepted
2012-06-01 17:00:05
Documents
1
Period of Report
2012-05-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d361795d8k.htm 8-K 27867
  Complete submission text file 0001193125-12-257348.txt   29196
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 12884030
SIC: 2835 In Vitro & In Vivo Diagnostic Substances